Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHN WILEY & SONS, INC.

(JW.A)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

John Wiley & Sons : Study Uncovers Potentially Avoidable Acute Care Use For Vaccine-Preventable Illnesses in Lupus Patients

05/05/2021 | 01:09am EDT

A new study published in Arthritis Care & Research indicates that few individuals with the autoimmune disease lupus who were publicly insured through Medicaid received recommended vaccines in 2000-2010. Also, those who were unvaccinated needed more acute care for vaccine-preventable illnesses.

From 2000-2010, there were 1,290 patients who visited the emergency department or were hospitalized for vaccine-preventable illness, and 93% of these visits occurred in patients without billing codes for related vaccinations. Patients who were Black had a 22% higher risk of needing such care than those who were white.

'These episodes represent missed opportunities to deliver essential preventive care to our patients, and particularly to patients with heightened vulnerabilities,' said lead author Candace H. Feldman, MD, ScD, of Brigham and Women's Hospital.

May is Lupus Awareness Month.

Additional Information

Link to Study: https://onlinelibrary.wiley.com/doi/10.1002/acr.24628

About Journal

Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Health Professionals (a division of the College), is a peer-reviewed publication that publishes original research, review articles, and editorials that promote excellence in the clinical practice of rheumatology. Relevant to the care of individuals with rheumatic diseases, major topics are evidence-based practice studies, clinical problems, practice guidelines, educational, social, and public health issues, health economics, health care policy, and future trends in rheumatology practice.

About Wiley

Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.

Disclaimer

John Wiley & Sons Inc. published this content on 05 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 May 2021 05:08:01 UTC.


ę Publicnow 2021
All news about JOHN WILEY & SONS, INC.
05/05JOHN WILEY & SONSá : New Study Identifies Quality Measures for End-of-Life Care ..
PU
05/05JOHN WILEY & SONSá : Many Patients With Cancer Are Experiencing Loneliness and R..
PU
05/05JOHN WILEY & SONSá : Which Medications Are Most Toxic to the Liver?
PU
05/05JOHN WILEY & SONSá : Do Bacteria in the Mouth Affect Risk of Developing Rheumato..
PU
05/05JOHN WILEY & SONSá : Erythropoietin Treatments May Increase Hip Fracture Risk in..
PU
05/05JOHN WILEY & SONSá : How Accurate Are Virtual Assessments of Cognitive Function?
PU
05/05JOHN WILEY & SONSá : The Online Learning Needs of Students Across Different Grad..
PU
05/05JOHN WILEY & SONSá : English as a Medium of Instruction in Higher Education Acro..
PU
05/05JOHN WILEY & SONSá : Light Pollution at Night Affects the Calls of Migratory Bir..
PU
05/05JOHN WILEY & SONSá : New Tool Offers Personalized, Low Environmental Impact, Hea..
PU
More news
Financials (USD)
Sales 2021 1 904 M - -
Net income 2021 139 M - -
Net Debt 2021 938 M - -
P/E ratio 2021 24,9x
Yield 2021 2,22%
Capitalization 3 435 M 3 435 M -
EV / Sales 2021 2,30x
EV / Sales 2022 2,19x
Nbr of Employees 6 900
Free-Float 52,3%
Chart JOHN WILEY & SONS, INC.
Duration : Period :
John Wiley & Sons, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHN WILEY & SONS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 55,33 $
Last Close Price 61,72 $
Spread / Highest target 0,45%
Spread / Average Target -10,3%
Spread / Lowest Target -22,2%
EPS Revisions
Managers and Directors
NameTitle
Brian A. Napack President, Chief Executive Officer & Director
John Anthony Kritzmacher Chief Financial Officer & Executive VP-Operations
Jesse C. Wiley Non-Executive Chairman
Aref Matin Chief Technology Officer & Executive VP
Raymond W. McDaniel Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHN WILEY & SONS, INC.34.17%3 414
S&P GLOBAL INC.15.51%91 465
RELX PLC1.79%49 331
THOMSON REUTERS CORPORATION9.91%46 733
MSCI INC.3.26%38 004
EQUIFAX INC.20.94%28 846